Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Company Overview More
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers’ data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.
CEO: Leasure Jr., Robert W.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Futubull > Quotes > NOTV Inotiv > Detailed Quotes

NOTV Inotiv

Watchlist
15.980+1.290+8.78%
Close 05/26 20:00 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
16.030
Open
14.720
Turnover
5.27M
Low
14.625
Pre Close
14.690
Volume
340.51K
Market Cap
407.73M
P/E(TTM)
Loss
52wk High
60.660
Shares
25.52M
P/E(Static)
84.11
52wk Low
11.251
Float Cap
223.01M
Bid/Ask %
66.67%
Historical High
60.660
Shs Float
13.96M
Volume Ratio
0.60
Historical Low
0.597
Dividend TTM
--
Div Yield TTM
--
P/B
0.66
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
2.44%
Amplitude
9.56%
Avg Price
15.474
Lot Size
1
Float Cap
223.01M
Bid/Ask %
66.67%
Historical High
60.660
Shs Float
13.96M
Volume Ratio
0.60
Historical Low
0.597
Dividend TTM
--
P/B
0.66
Dividend LFY
--
Turnover Ratio
2.44%
Amplitude
9.56%
Avg Price
15.474
Lot Size
1
Price Forecast

No Data

News

Comment

Back to the Top